American Gene Technologies®
In The News
iHeart Radio Recognizes Jeff Galvin as a “CEO You Should Know”
Subscribe to our YouTube Channel “CEOs You Should Know” is a weekly radio program sponsored by M&T Bank that profiles local companies and their leaders who drive the Greater Washington, D.C. regional economy. As a leader in DC’s business community, iHeart radio invited CEO of…
Read More
BioTalk with Rich Bendis
Listen On: Apple | Google | Spotify | TuneIn American Gene Technologies (AGT) CEO and Founder, Jeff Galvin, returns to BioTalk to share updates on their work for a potential functional cure for HIV, the growth of his company, and where they are going next.…
Read More
Bethesda Magazine: On the Cusp of a Cure?
Published on: Bethesda Magazine | BY DAVID GOLDSTEIN Jeff Galvin believes his Rockville cell and gene technology company has found a breakthrough treatment for people living with HIV When Jeff Galvin was 13 years old, he came across a lone computer in the basement of Muzzey…
Read More
ABC 7 News WJLA: “Montgomery Co. biotech company receives FDA approval for human trials of HIV Cure program”
Subscribe to our YouTube Channel Written by: Justin Hinton MONTGOMERY COUNTY, Md. (ABC7) – A Montgomery County-based biotechnology company has announced it received approval from the FDA to begin human trials for its HIV cure program. American Gene Technologies has been developing its program for 12…
Read More
CBS News Baltimore WJZ: “FDA Clears Maryland Company’s Potential HIV Cure For Human Trials”
Subscribe to our YouTube Channel Written by: CBS Baltimore Staff ROCKVILLE, Md. (WJZ) – The U.S. Food and Drug Administration has approved a Maryland company’s potential HIV cure for human trials, the company announced this week. Rockville-based American Gene Technologies said in a news release it will…
Read More
DVM-270 News: “Rockville lab to begin trials in attempt to cure HIV”
Subscribe to our YouTube Channel Written by: Shennekia Grimshaw ROCKVILLE, Md. (WDVM) – As millions of people around the world are infected with HIV, a Rockville company believes it might be close to finding a cure. American Gene Technologies got the green light by the…
Read More
Molecular Therapy: “Preclinical Development and Clinical-Scale Manufacturing of HIV Gag-Specific, Lentivirus Modified CD4 T Cells for HIV Functional Cure”
Original Article: Molecular Therapy: Methods & Clinical Development Vol. 17 June 2020 Haishan Li,1 Tyler Lahusen,1 Lingzhi Xiao,1 Nidal Muvarak,1 Jana Blazkova,2 Tae-Wook Chun,2 and C. David Pauza1 1American Gene Technologies International, Rockville, MD, USA; 2Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases…
Read More
BioNeex Interview with CEO of American Gene Technologies, Jeff Galvin
Subscribe to AGT’s YouTube Channel BioNeex, a Biopharmaceutical R&D exchange platform for compounds licensing and co-development partnerships, created an interview series of innovative CEOs and executives to provide value to its customers and the biotechnology industry. Founder Dr. Smbat Rafayelyan interviewed AGT CEO Jeff Galvin…
Read More
BioSpace: “AGT CEO Jeff Galvin on the Future of the Gene and Cell Therapy Industry”
The rapid growth of biopharma is causing a shift to a new paradigm for the drug development and delivery model. In the same manner that the personal computing industry grew and developed business models that fit the way products were sourced, constructed and delivered, a…
Read More
Zacks SCR: “American Gene Technologies: The Software Revolution For The Next 100 Years”
Published by: Zacks Small Cap Research (SCR) | Written by: John Vandermosten, CFADownload The Full PDF American Gene Technologies (AGT) is a genetic medicines company developing a portfolio of therapies that employ the company’s proprietary lentiviral vector (LV) platform to focus on disease in areas…
Read MoreSubscribe to News Releases and News Updates
Subscribe to our news release and published article updates to be notified when we release new content!
Follow AGT on Social Media
AGT on Facebook
How does Jeff Galvin THINK? - Addimmune
bit.ly
Jeff Galvin, CEO of American Gene Technologies® (AGT ™) and Addimmune™, has seen firsthand what gene and cell therapies can do.
How does Jeff Galvin THINK? - Addimmune
bit.ly
Jeff Galvin, CEO of American Gene Technologies® (AGT ™) and Addimmune™, has seen firsthand what gene and cell therapies can do.
